Europe’s psychedelic science renaissance has started
The Old World has had its own remarkable history concerning psychedelic research – it was after all the continent where Albert Hofmann first discovered LSD and where Dutch professor Jan Bastiaans treated the trauma of [...]
Ketamine could be the first rapid-acting antidepressant medication
Ketamine has been used for over half a century as an anaesthetic, but interest has been steadily growing in its ability to rapidly decrease depressive symptoms. This interest has culminated in many studies attempting to [...]
Psilocybin-assisted therapy shows promising results for treatment-resistant depression
In a new study, the research team at the Imperial College London has tested the potential of psilocybin-assisted therapy to alleviate treatment-resistant depression. Statistics show that 20% of people suffering from major depression are unresponsive [...]
The Serotonin Infatuation
Much like the Holy Grail symbolised well-being, infinite wealth, and abundance of food in Arthurian literature, today the infamous neurotransmitter, serotonin, is linked with mood, attention, hunger and more (Young & Leyton, 2002; Wingen, et [...]
Does Android Dream of Electric Dogs? Some parallels between Google’s Deep Dream and psychedelic visuals
Deep Dream, the program used in Google’s image generation technique, was released to the public in July 2015. Dubbed Inceptionism by the researchers, it soon drew quite [...]
Psychedelic Research 2.0 – Part 1
After a 20 year study-shutdown on psychedelics, a second wave of interest in the nature and applications of these compounds has engulfed the international research community and rendered a wealth of studies. To help you [...]
The Therapeutic Potentials of Salvinorin A
Salvia divinorum is a sprawling perennial herb found in the Sierra Mazatec region of Mexico. It has a history of use as a divinatory psychedelic, and has been widely available since the mid 1990s primarily [...]
Autism and LSD-25 – Freeing the Most Imprisoned Minds?
In the early sixties, a number of controversial clinical investigations were published involving the administration of LSD-25 (lysergic acid diethylamide) to young children said to suffer from severe forms of autism, or childhood-onset schizophrenia (COS), [...]
Ketamine Reconsidered
Ketamine is causing a lot of ‘buzz’ inside neuropsychiatry at the moment. Duman and Aghajanian called the substance in Science (2012) “the biggest breakthrough in depression research in a half century”. The APA (American Psychiatric [...]